about
Diagnosis and management of hypertrophic cardiomyopathyGenetic determinants of myocardial dysfunction.The role of magnetic resonance imaging in hypertrophic cardiomyopathy.In vivo cardiovascular magnetic resonance diffusion tensor imaging shows evidence of abnormal myocardial laminar orientations and mobility in hypertrophic cardiomyopathy.Desensitization of myofilaments to Ca2+ as a therapeutic target for hypertrophic cardiomyopathy with mutations in thin filament proteins.Rescue of familial cardiomyopathies by modifications at the level of sarcomere and Ca2+ fluxes.Cardiomyopathies: Evolution of pathogenesis concepts and potential for new therapies.LAMP2 microdeletions in patients with Danon disease.MYH11 mutations result in a distinct vascular pathology driven by insulin-like growth factor 1 and angiotensin IILarge scale pedigree analysis leads to evidence for founder effects of Hypertrophic Cardiomyopathy in Rhesus Macaques (Macaca mulatta).Association of noninvasively measured left ventricular mechanics with in vitro muscle contractile performance: a prospective study in hypertrophic cardiomyopathy patients.New insights into the pathology of inherited cardiomyopathy.Histologic characterization of hypertrophic cardiomyopathy with and without myofilament mutations.The diagnosis of hypertrophic cardiomyopathy by cardiovascular magnetic resonance.Genetics of inherited cardiomyopathies.Reproducibility of in-vivo diffusion tensor cardiovascular magnetic resonance in hypertrophic cardiomyopathyLeft Ventricular Hypertrophy in Rhesus Macaques (Macaca mulatta) at the California National Primate Research Center (1992-2014)Morphological and molecular changes of the myocardium after left ventricular mechanical supportTaxonomy of segmental myocardial systolic dysfunction.Overview of sudden cardiac death in young athletes.Postmortem imaging of sudden cardiac death.Sudden cardiac death in patients with nonischemic cardiomyopathy.Vitamin K antagonist use for all patients with hypertrophic cardiomyopathy and atrial fibrillation: analysis of the literature and guideline review.A comparison of genetic findings in sudden cardiac death victims and cardiac patients: the importance of phenotypic classification.Passive ventricular remodeling in cardiac disease: focus on heterogeneity.SPontaneous Oscillatory Contraction (SPOC): auto-oscillations observed in striated muscle at partial activationDistinguishing ventricular septal bulge versus hypertrophic cardiomyopathy in the elderly.Prevention of sudden death in hypertrophic cardiomyopathy: bridging the gaps in knowledge.Direct comparison of the diagnostic capability of cardiac magnetic resonance and endomyocardial biopsy in patients with heart failure.Biomarker and imaging responses to spironolactone in subclinical diabetic cardiomyopathy.Cell type-specific functions of the lysosomal protease cathepsin L in the heart.Guidelines for autopsy investigation of sudden cardiac death: 2017 update from the Association for European Cardiovascular Pathology.Identifying unmet clinical need in hypertrophic cardiomyopathy using national electronic health records.Radiology and pathology correlation in common infiltrative cardiomyopathies.Three-dimensional speckle tracking echocardiography for the preclinical diagnosis of hypertrophic cardiomyopathy.Left Ventricular Wall Stress Is Sensitive Marker of Hypertrophic Cardiomyopathy With Preserved Ejection Fraction.
P2860
Q26773621-E4522579-E34C-4DC6-AEEC-BFA0074A0E1AQ30240839-039A609C-D818-48AB-BEEA-ECC38DC4D93AQ30426380-AD9D6085-2F69-4A84-A3D0-3317A87C0CDDQ30868844-13087335-DF0B-47D2-B80C-A37CC0AA5392Q33771564-E758CA42-6BF6-4163-BBA3-D74A0C2B0CB2Q33787794-68DD5E95-41E0-4AC3-AC94-A39BA05971A5Q33812953-26B63C0D-8B9A-421A-8FF6-BDDEAD51019AQ33954482-65847FDC-9AE1-4A13-98D9-68B9EF478BE1Q34000032-A83B8546-646D-4B28-8487-3256A116AA97Q34557443-84A6BC26-E4E0-413E-9DE8-75A34F428C8FQ35115012-907C8868-72EF-4C47-8AE4-B9375D9B399CQ35583633-B1DB74DB-3BE7-4827-A3C4-BCAF306927AAQ35762855-F0F27959-6317-4178-BBA9-D2330374D62FQ35845452-84E70F2B-1C72-4783-B32B-60E4F191950BQ35879073-59E2FEB3-8B6E-4A6C-9333-7D67AAE38E22Q36552532-790D5A75-1C43-4FEA-B37C-7C98C228BD04Q36781777-2E040C72-8564-40E5-8D4D-717232EB203CQ37638247-FA5C0AB5-34D5-4DCB-8C7B-B31A88CEA12EQ37738593-9FDB6A10-F2A4-4FDB-8D17-5AC319DB0664Q37980342-A2D0D2BB-D4D0-499B-A626-E32757629776Q38074319-31B685CE-B8BD-4222-97F7-95CDAB30E4D4Q38191069-90220C65-016D-4090-8CD2-3460C1998184Q38206840-97D90143-6CB9-4F33-90D5-A8B74A7B7687Q38262818-7F1D1DE4-45FB-45CC-A3C3-C4DB706CF531Q38310158-0281E38C-F90D-472D-A537-9364A63172D3Q38783131-2AE43308-6F42-49FA-B74E-652397C64803Q38819503-9786F19B-ADFC-4710-B6FD-0C583EE33575Q38884022-AD742361-8D70-4397-9D03-F43039FDA3EEQ44492573-2AC2ED1D-AD57-4B40-B16C-86C7A2119BFBQ44565921-7F295A52-9157-4FE6-9554-FE606485F364Q46945604-10CDCFE6-4757-4805-8470-9CA58F1D6459Q47096866-DC6639E0-9323-4D36-9C69-EE88F08D4060Q48259549-F05C9F3D-66EA-4CA5-845D-B881223BF67FQ50546338-8032EA2A-0258-4C64-96CA-A8821B0A1F88Q50623814-FCBF4DF8-0AA9-4FBF-92BF-AFBFAE2C0C4BQ55086178-F9CD4CEA-5CD5-4CD1-BB41-49EE7C0A0312
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
The pathology of hypertrophic cardiomyopathy.
@ast
The pathology of hypertrophic cardiomyopathy.
@en
type
label
The pathology of hypertrophic cardiomyopathy.
@ast
The pathology of hypertrophic cardiomyopathy.
@en
prefLabel
The pathology of hypertrophic cardiomyopathy.
@ast
The pathology of hypertrophic cardiomyopathy.
@en
P2860
P1433
P1476
The pathology of hypertrophic cardiomyopathy.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2559.2004.01835.X
P577
2004-05-01T00:00:00Z